DTC:CC News and Press, Defence Therapeutics Inc. Class A

News Releases

DTC:CC News Releases

July 08, 2026 03:15:00 am

DTC:CC : CNQC

TMX Newsfile

Defence Therapeutics Opens New Office in Hamilton to Expand Its Accum Radiopharmaceutical Platform

June 29, 2026 10:00:35 am

DTC:CC : CNQC

QM Canadian Market Movers

Canadian Companies Moving the Markets, Morning edition
Mon, Jun 29, 2026 as of 10.00 am ET

June 17, 2026 03:15:00 am

DTC:CC : CNQC

TMX Newsfile

Defence Therapeutics to Participate in Bio International Convention 2026 Next Week for Strategic Partnership Discussions

June 03, 2026 03:15:00 am

DTC:CC : CNQC

TMX Newsfile

Defence Therapeutics Appoints Seasoned Biopharmaceutical Executive Dr John Beaver to Its Board of Directors

June 01, 2026 03:15:00 am

DTC:CC : CNQC

TMX Newsfile

Defence Therapeutics Appoints Antibody Drug Conjugates Pioneer Dr. John Lambert to Its Board of Directors

May 29, 2026 04:30:00 pm

DTC:CC : CNQC

TMX Newsfile

Defence Therapeutics Strengthens Its Scientific Advisory Board with the Appointment of Dr. Sarkis Meterissian

May 19, 2026 03:15:00 am

DTC:CC : CNQC

TMX Newsfile

Defence Therapeutics Enhances In-House ADC Development Platform with Expanded Analytical and Cellular Testing Capabilities

April 24, 2026 06:30:00 pm

DTC:CC : CNQC

TMX Newsfile

Defence Therapeutics Announces Grant of Restricted Stock Units

March 20, 2026 06:00:00 pm

DTC:CC : CNQC

TMX Newsfile

Defence Therapeutics Announces Warrant Terms Amendment

March 09, 2026 03:15:00 am

DTC:CC : CNQC

TMX Newsfile

Defence Therapeutics Announces Closing of Private Placement of Units for Gross Proceeds of $9,595,000

	Next 10

Defence Therapeutics Inc. Class A (CNQC : DTC:CC ) News

News Releases

Subscribe to Our Newsletter

Download The Market Wire News App

Schedule a 30 minute Brand Awareness meeting with Market Wire News

Link Market Wire News to Your X Account